|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|
| Cash flows from operating activities: | ||
| Net loss | ||
| Adjustments to reconcile net loss to net cash used in operating activities | ||
| Share-based compensation | ||
| Accretion of asset retirement obligations | ||
| Bad debt expense | ||
| Depreciation and amortization | ||
| Gain (loss) on disposal of property and equipment | ||
| Noncash operating lease expense | ||
| Accretion of discount on short-term investments, net | ||
| Impairment of long-lived assets | ||
| Non-cash research and development expense | ||
| Change in fair value of related party convertible loan | ||
| Gain on loan extinguishment | ||
| Other adjustments | ||
| Changes in operating assets and liabilities: | ||
| Accounts receivable | ||
| Prepaid expenses and other current assets | ||
| Other assets | ||
| Accounts payable | ||
| Amounts due to related parties | ||
| Amounts due to joint development partners | ||
| Accrued expenses and other current liabilities | ||
| Operating lease liabilities | ||
| Other liabilities | ||
| Net cash used in operating activities | ||
| Cash flows from investing activities: | ||
| Advances to related parties | ||
| Repayments from advances to related parties | ||
| Purchases of short-term investments | ||
| Proceeds from maturities of short-term investments | ||
| Purchases of property and equipment | ||
| Proceeds from disposal of property and equipment | ||
| Purchases of intangible assets | ||
| Net cash used in investing activities | ||
| Cash flows from financing activities: | ||
| Proceeds from issuance of redeemable convertible preferred stock | ||
| Proceeds from issuance of common stock under the Employee Stock Purchase Plan | ||
| Proceeds from exercise of warrants for redeemable convertible preferred stock | ||
| Proceeds from issuance of related party convertible loan | ||
| Proceeds from issuance of warrants | ||
| Proceeds from exercised stock options | ||
| Proceeds from issuance of common stock upon initial public offering, net of offering costs | ||
| Proceeds from issuance of common stock related to private placement | ||
| Proceeds from related party loan | ||
| Proceeds from loans | ||
| Return of guarantee deposit on related party loan | ||
| Principal payments on related party loan | ||
| Payment of third-party costs in connection with initial public offering | ||
| Principal payments on capital and finance lease obligations | ||
| Principal payments on loans | ||
| Net cash provided by financing activities | ||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | ||
| Net increase (decrease) in cash, cash equivalents and restricted cash | ||
| Cash, cash equivalents and restricted cash at beginning of period | ||
| Cash, cash equivalents and restricted cash at end of period | ||
| Supplemental disclosure of cash flow information: | ||
| Cash paid for interest | ||
| Supplemental schedule of non-cash investing and financing activities: | ||
| Acquisitions of property and equipment included in liabilities | ||
| Purchase of property and equipment under capital lease | ||
| Exchange of Series A-2 redeemable convertible preferred stock for common stock | ||
| Accretion of redeemable convertible preferred stock | ||
| Reclassification of Series D-1 redeemable convertible preferred share warrants from equity to liabilities | ||
| Cashless exercise of share options for common stock | ||
| Conversion of related party convertible loan to Series E-1 redeemable convertible preferred shares | ||
| Vesting of early exercised stock options | ||
| Exercise of liability-classified warrants | ||
| Conversion of redeemable convertible preferred stock into common stock upon initial public offering | ||
| Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets: | ||
| Cash and cash equivalents | ||
| Restricted cash included in prepaid expenses and other current assets |
Loading...
